These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 879208)

  • 1. Vaginal prostaglandin E2 for missed abortion and intrauterine fetal death.
    Rutland A; Ballard C
    Am J Obstet Gynecol; 1977 Jul; 128(5):503-6. PubMed ID: 879208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2 induction of abortion and fetal demise.
    Wiley TL; Poole CP; Gookin KS; Wiser WL; Morrison JC
    Int J Gynaecol Obstet; 1989 Feb; 28(2):171-5. PubMed ID: 2563705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of intrauterine fetal demise and missed abortion using prostaglandin E2 vaginal suppositories.
    Southern EM; Gutknecht GD
    Obstet Gynecol; 1976 May; 47(5):602-6. PubMed ID: 1264407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of prostaglandin E2 vaginal suppositories in intrauterine fetal death and missed abortion.
    Bailey CD; Newman C; Ellinas SP; Anderson GG
    Obstet Gynecol; 1975 Jan; 45(1):110-3. PubMed ID: 1110809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of intrauterine fetal death with prostaglandin E2 vaginal suppositories.
    Lauersen NH; Cederqvist LL; Wilson KH
    Am J Obstet Gynecol; 1980 Aug; 137(7):753-7. PubMed ID: 7405965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
    Lauersen NH; Wilson KH
    Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prostaglandin analogue (ONO-802) in treatment of missed abortion, intrauterine fetal death and hydatiform mole: a dose-finding trial.
    Garcea N; Dargenio R; Panetta V; Moneta E; Tancredi G; Giannitelli A
    Eur J Obstet Gynecol Reprod Biol; 1987 May; 25(1):15-22. PubMed ID: 3595971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous intravenous infusion of prostaglandin E2 (PGE2) and oxytocin in the management of intrauterine death of the fetus, missed abortion and hydatidiform mole.
    Naismith WC; Barr W
    J Obstet Gynaecol Br Commonw; 1974 Feb; 81(2):146-9. PubMed ID: 4816026
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaginal prostaglandin E2 in the management of fetal intrauterine death.
    Southern EM; Gutknecht GD; Mohberg NR; Edelman DA
    Br J Obstet Gynaecol; 1978 Jun; 85(6):437-41. PubMed ID: 350261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of labor in patients with missed abortion and fetal death in utero with protaglandin E2 suppositories.
    Lauersen NH; Wilson KH
    Am J Obstet Gynecol; 1977 Mar; 127(6):609-11. PubMed ID: 557289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison between vaginal prostaglandin E2 suppositories and intrauterine extra-amniotic prostaglandins in the management of fetal death in utero.
    Scher J; Jeng DY; Moshirpur J; Kerenyi TD
    Am J Obstet Gynecol; 1980 Aug; 137(7):769-72. PubMed ID: 7405968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of the third stage of labor in pregnancies terminated by prostaglandin E2.
    Kirz DS; Haag MK
    Am J Obstet Gynecol; 1989 Feb; 160(2):412-4. PubMed ID: 2916627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal administration of prostaglandin F2alpha for inducing therapeutic abortion.
    Brenner WE; Hendricks CH; Braaksma JT; Fishburne JI; Staurovsky LG
    Prostaglandins; 1972 Jun; 1(6):455-67. PubMed ID: 4660080
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of prostaglandin E2 vaginal suppository in missed abortion, intrauterine death and hydatidiform mole.
    Takagi LR; Gulling EA; O'Leary JA
    J Med Assoc Ga; 1978 Aug; 67(8):644-5. PubMed ID: 574529
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaginal prostaglandin E2 for interruption of pregnancy and management of intrauterine death.
    Thiery M; Amy JJ; Decoster JM
    Z Geburtshilfe Perinatol; 1979 Jun; 183(3):218-22. PubMed ID: 483950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of 16-16 dimethyl trans delta 2 PGE1 methyl ester (ONO 802) vaginal suppositories for the termination of early pregnancy. A comparative study.
    Smith SK; Baird DT
    Br J Obstet Gynaecol; 1980 Aug; 87(8):712-7. PubMed ID: 7426533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mid-trimester abortion induced by intravaginal administration of prostaglandin E2 suppositories.
    Lauersen NH; Secher NJ; Wilson KH
    Am J Obstet Gynecol; 1975 Aug; 122(8):947-54. PubMed ID: 1155530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
    Bolognese RJ; Corson SL
    Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 induced abortion with vaginal suppositories in a contraceptive diaphragm.
    Schulman H; Saldana L; Tsai T; Leibman T; Cunningham M; Randolph G
    Prostaglandins; 1974 Aug; 7(3):195-205. PubMed ID: 4415347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of missed abortion by intramuscular administration of 15(S) 15 methyl prostaglandin F2 alpha.
    Mapa MK; Singh PM; Misra I
    Asia Oceania J Obstet Gynaecol; 1982 Dec; 8(4):369-72. PubMed ID: 7171346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.